Understanding Pseudomonas aeruginosa–Host Interactions: The Ongoing Quest for an Efficacious Vaccine
Autor: | Siobhán McClean, Maite Sainz-Mejías, Irene Jurado-Martín |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Lipopolysaccharides Cystic Fibrosis virulence factors Review medicine.disease_cause Cystic fibrosis immune response Mice Pseudomonas aeruginosa ESKAPE host-pathogen interactions vaccine antigens adjuvants Vaccines DNA Longitudinal Studies Pathogen lcsh:QH301-705.5 Lung Respiratory Tract Infections General Medicine Antimicrobial Antibodies Bacterial 3. Good health Flagella Pseudomonas Vaccines Alginates 030106 microbiology Exotoxins 03 medical and health sciences Antibiotic resistance Immune system Th2 Cells Antigen Adjuvants Immunologic medicine Animals Humans Pseudomonas Infections Antigens business.industry Host (biology) Th1 Cells medicine.disease Immunity Innate 030104 developmental biology lcsh:Biology (General) Immunology Th17 Cells business |
Zdroj: | Cells Cells, Vol 9, Iss 2617, p 2617 (2020) |
ISSN: | 2073-4409 |
DOI: | 10.3390/cells9122617 |
Popis: | Pseudomonas aeruginosa is a leading cause of chronic respiratory infections in people with cystic fibrosis (CF), bronchiectasis or chronic obstructive pulmonary disease (COPD), and acute infections in immunocompromised individuals. The adaptability of this opportunistic pathogen has hampered the development of antimicrobial therapies, and consequently, it remains a major threat to public health. Due to its antimicrobial resistance, vaccines represent an alternative strategy to tackle the pathogen, yet despite over 50 years of research on anti-Pseudomonas vaccines, no vaccine has been licensed. Nevertheless, there have been many advances in this field, including a better understanding of the host immune response and the biology of P. aeruginosa. Multiple antigens and adjuvants have been investigated with varying results. Although the most effective protective response remains to be established, it is clear that a polarised Th2 response is sub-optimal, and a mixed Th1/Th2 or Th1/Th17 response appears beneficial. This comprehensive review collates the current understanding of the complexities of P. aeruginosa-host interactions and its implication in vaccine design, with a view to understanding the current state of Pseudomonal vaccine development and the direction of future efforts. It highlights the importance of the incorporation of appropriate adjuvants to the protective antigen to yield optimal protection. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |